{
  "AAQ1.DE": {
    "city": "Berlin",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "GER",
    "industry": "Medical Devices",
    "long_name": "aap Implantate AG",
    "market": "de_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "AAP IMPLANTATE AG O.N.",
    "state": null,
    "summary": "aap Implantate AG, a medical device company, develops, manufactures, and markets trauma products for orthopedics in Germany, the United States, and internationally. It offers LOQTEQ, an anatomical plating system for fracture treatment; and a range of cannulated screws, standard plates, and screws. The company sells its products directly to hospitals, buying syndicates, and hospital groups, as well as through a network of distributors under the aap brand name. aap Implantate AG was founded in 1990 and is headquartered in Berlin, Germany.",
    "website": "http://www.aap.de",
    "zipcode": "12099"
  },
  "AAQ1.F": {
    "city": "Berlin",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "aap Implantate AG",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "AAP IMPLANTATE AG O.N.",
    "state": null,
    "summary": "aap Implantate AG, a medical device company, develops, manufactures, and markets trauma products for orthopedics in Germany, the United States, and internationally. It offers LOQTEQ, an anatomical plating system for fracture treatment; and a range of cannulated screws, standard plates, and screws. The company sells its products directly to hospitals, buying syndicates, and hospital groups, as well as through a network of distributors under the aap brand name. aap Implantate AG was founded in 1990 and is headquartered in Berlin, Germany.",
    "website": "http://www.aap.de",
    "zipcode": "12099"
  },
  "DGWPF": {
    "city": "LÃ¼beck",
    "country": "Germany",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Drägerwerk AG & Co. KGaA",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "DRAEGERWERK AG & CO KGAA",
    "state": null,
    "summary": "DrÃ¤gerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care. It also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. The company's products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, and system products. Its product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, professional diving equipment and systems, and alcohol and drug testing devices. In addition, the company offers various training and services, as well as undertakes projects that include fire training systems. DrÃ¤gerwerk AG & Co. KGaA was founded in 1889 and is headquartered in LÃ¼beck, Germany.",
    "website": "http://www.draeger.com",
    "zipcode": "23558"
  },
  "DRW1.F": {
    "city": "LÃ¼beck",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Drägerwerk AG & Co. KGaA",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "DRAEGERWERK GEN.S.D",
    "state": null,
    "summary": "DrÃ¤gerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care. It also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. The company's products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, and system products. Its product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, professional diving equipment and systems, and alcohol and drug testing devices. In addition, the company offers various training and services, as well as undertakes projects that include fire training systems. DrÃ¤gerwerk AG & Co. KGaA was founded in 1889 and is headquartered in LÃ¼beck, Germany.",
    "website": "http://www.draeger.com",
    "zipcode": "23558"
  },
  "DRW3.DE": {
    "city": "LÃ¼beck",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "GER",
    "industry": "Medical Devices",
    "long_name": "Drägerwerk AG & Co. KGaA",
    "market": "de_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "DRAEGERWERK VZO O.N.",
    "state": null,
    "summary": "DrÃ¤gerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care. It also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. The company's products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, and system products. Its product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, professional diving equipment and systems, and alcohol and drug testing devices. In addition, the company offers various training and services, as well as undertakes projects that include fire training systems. DrÃ¤gerwerk AG & Co. KGaA was founded in 1889 and is headquartered in LÃ¼beck, Germany.",
    "website": "http://www.draeger.com",
    "zipcode": "23558"
  },
  "DRW3.F": {
    "city": "LÃ¼beck",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Drägerwerk AG & Co. KGaA",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "DRAEGERWERK VZO O.N.",
    "state": null,
    "summary": "DrÃ¤gerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care. It also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. The company's products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, and system products. Its product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, professional diving equipment and systems, and alcohol and drug testing devices. In addition, the company offers various training and services, as well as undertakes projects that include fire training systems. DrÃ¤gerwerk AG & Co. KGaA was founded in 1889 and is headquartered in LÃ¼beck, Germany.",
    "website": "http://www.draeger.com",
    "zipcode": "23558"
  },
  "DRW3.VI": {
    "city": "LÃ¼beck",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "VIE",
    "industry": "Medical Devices",
    "long_name": "Drägerwerk AG & Co. KGaA",
    "market": "at_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "DRAEGERWERK AG VZ",
    "state": null,
    "summary": "DrÃ¤gerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care. It also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. The company's products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, and system products. Its product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, professional diving equipment and systems, and alcohol and drug testing devices. In addition, the company offers various training and services, as well as undertakes projects that include fire training systems. DrÃ¤gerwerk AG & Co. KGaA was founded in 1889 and is headquartered in LÃ¼beck, Germany.",
    "website": "http://www.draeger.com",
    "zipcode": "23558"
  },
  "DRW8.DE": {
    "city": "LÃ¼beck",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "GER",
    "industry": "Medical Devices",
    "long_name": "Drägerwerk AG & Co. KGaA",
    "market": "de_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "DRAEGERWERK ST.A.O.N.",
    "state": null,
    "summary": "DrÃ¤gerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care. It also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. The company's products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, and system products. Its product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, professional diving equipment and systems, and alcohol and drug testing devices. In addition, the company offers various training and services, as well as undertakes projects that include fire training systems. DrÃ¤gerwerk AG & Co. KGaA was founded in 1889 and is headquartered in LÃ¼beck, Germany.",
    "website": "http://www.draeger.com",
    "zipcode": "23558"
  },
  "DRW8.F": {
    "city": "LÃ¼beck",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Drägerwerk AG & Co. KGaA",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "DRAEGERWERK ST.A.O.N.",
    "state": null,
    "summary": "DrÃ¤gerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care. It also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. The company's products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, and system products. Its product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, professional diving equipment and systems, and alcohol and drug testing devices. In addition, the company offers various training and services, as well as undertakes projects that include fire training systems. DrÃ¤gerwerk AG & Co. KGaA was founded in 1889 and is headquartered in LÃ¼beck, Germany.",
    "website": "http://www.draeger.com",
    "zipcode": "23558"
  },
  "E8X.DE": {
    "city": "Singen",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "GER",
    "industry": "Medical Devices",
    "long_name": "elexxion AG",
    "market": "de_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "ELEXXION AG",
    "state": null,
    "summary": "elexxion AG develops, produces, and sells dental lasers for soft and hard tissue applications primarily in Germany. It offers dental diode lasers under the elexxion pico, elexxion nano, and elexxion claros names; and elexxion pico lite, a soft laser therapy. The company also provides Odobleach; and perio green, a therapy product for the photothermal therapy of periodontology and periimplantitis, as well as offers repair services. The company was founded in 2002 and is based in Singen, Germany. elexxion AG is a subsidiary of Tian Ying Medical Instrument Co., Ltd.",
    "website": "http://www.elexxion.com",
    "zipcode": "78224"
  },
  "E8X.F": {
    "city": "Singen",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "elexxion AG",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "ELEXXION AG",
    "state": null,
    "summary": "elexxion AG develops, produces, and sells dental lasers for soft and hard tissue applications primarily in Germany. It offers dental diode lasers under the elexxion pico, elexxion nano, and elexxion claros names; and elexxion pico lite, a soft laser therapy. The company also provides Odobleach; and perio green, a therapy product for the photothermal therapy of periodontology and periimplantitis, as well as offers repair services. The company was founded in 2002 and is based in Singen, Germany. elexxion AG is a subsidiary of Tian Ying Medical Instrument Co., Ltd.",
    "website": "http://www.elexxion.com",
    "zipcode": "78224"
  },
  "EUZ.DE": {
    "city": "Berlin",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "GER",
    "industry": "Medical Devices",
    "long_name": "Eckert & Ziegler Strahlen- und Medizintechnik AG",
    "market": "de_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "ECKERT+ZIEGLER AG O.N.",
    "state": null,
    "summary": "Eckert & Ziegler Strahlen- und Medizintechnik AG, through its subsidiaries, provides isotope technology components for medical, scientific, and industrial use worldwide. It operates through three segments: Radiation Therapy, Radiopharma, and Isotope Products. The Radiation Therapy segment develops, manufactures, markets, and sells radioactive products for cancer therapy. This segment offers small radioactive implants for the treatment of prostate cancer seeds; and tumor radiation devices and eye applicators. This segment's products and equipment are used by oncologists, radiotherapists, urologists, ophthalmologists, and medical physicists. The Radiopharma segment operates in the field of molecular imaging and nuclear medicine; and supplies various radiopharmaceuticals, radiochemicals, and related equipment for the synthesis and radiochromatography of PET/SPECT tracers and other radioisotopes. This segment provides products in the categories of radiosynthesis technology, radiochromatography, and radionuclides. The Isotope Products segment offers sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration, and environmental monitoring sources and solutions; and bulk radioisotopes for pharmaceutical, therapeutic, and industrial product manufacturers. It also provides custom and one-off design and manufacturing services. In addition, the company offers services for collection, recycling, and disposal of sealed radioactive sources and low activity isotope related waste from hospitals, research institutes, and industries. Eckert & Ziegler Strahlen- und Medizintechnik AG was founded in 1992 and is headquartered in Berlin, Germany.",
    "website": "http://www.ezag.com",
    "zipcode": "13125"
  },
  "EUZ.F": {
    "city": "Berlin",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Eckert & Ziegler Strahlen- und Medizintechnik AG",
    "market": "dr_market",
    "market_cap": "Mid Cap",
    "sector": "Healthcare",
    "short_name": "ECKERT+ZIEGLER AG O.N.",
    "state": null,
    "summary": "Eckert & Ziegler Strahlen- und Medizintechnik AG, through its subsidiaries, provides isotope technology components for medical, scientific, and industrial use worldwide. It operates through three segments: Radiation Therapy, Radiopharma, and Isotope Products. The Radiation Therapy segment develops, manufactures, markets, and sells radioactive products for cancer therapy. This segment offers small radioactive implants for the treatment of prostate cancer seeds; and tumor radiation devices and eye applicators. This segment's products and equipment are used by oncologists, radiotherapists, urologists, ophthalmologists, and medical physicists. The Radiopharma segment operates in the field of molecular imaging and nuclear medicine; and supplies various radiopharmaceuticals, radiochemicals, and related equipment for the synthesis and radiochromatography of PET/SPECT tracers and other radioisotopes. This segment provides products in the categories of radiosynthesis technology, radiochromatography, and radionuclides. The Isotope Products segment offers sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration, and environmental monitoring sources and solutions; and bulk radioisotopes for pharmaceutical, therapeutic, and industrial product manufacturers. It also provides custom and one-off design and manufacturing services. In addition, the company offers services for collection, recycling, and disposal of sealed radioactive sources and low activity isotope related waste from hospitals, research institutes, and industries. Eckert & Ziegler Strahlen- und Medizintechnik AG was founded in 1992 and is headquartered in Berlin, Germany.",
    "website": "http://www.ezag.com",
    "zipcode": "13125"
  },
  "GME.DE": {
    "city": "Geschwenda",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "GER",
    "industry": "Medical Devices",
    "long_name": "Geratherm Medical AG",
    "market": "de_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "GERATHERM O.N.",
    "state": null,
    "summary": "Geratherm Medical AG operates as a medical technology company in Germany. The company operates through Healthcare Diagnostic, Respiratory, Cardio/Stroke, and Medical Warming Systems segments. The Healthcare Diagnostic segment primarily offers clinical thermometers; blood pressure monitors; and self-test diagnostic products for women, including pregnancy tests, chlamydia tests, urinary tract infection, diverse ovulation test solutions, and pH tests. The Respiratory segment develops and manufactures products under the Spirostik and Spirostik Complete names, principally for the pulmonary and cardiopulmonary function diagnostics. The Medical Warming Systems segment provides warming systems under the UniqueTemp and Unique Resc+ brand names to maintain body temperature during operations and in rescue situations; and nomag IC, an incubator system for use in magnetic resonance imaging of premature and newborn infants under the LMT brand. The Cardio/Stroke segment offers stroke risk analysis products for the detection of atrial fibrillation used in preventing strokes. It markets its products through pharmacies, hospitals, and clinics. The company exports its products to Europe, South America, the Middle East, Asia, Africa, the United States, and internationally. Geratherm Medical AG is headquartered in Geschwenda, Germany.",
    "website": "http://www.geratherm.com",
    "zipcode": "99331"
  },
  "GME.F": {
    "city": "Geschwenda",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Geratherm Medical AG",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "GERATHERM O.N.",
    "state": null,
    "summary": "Geratherm Medical AG operates as a medical technology company in Germany. The company operates through Healthcare Diagnostic, Respiratory, Cardio/Stroke, and Medical Warming Systems segments. The Healthcare Diagnostic segment primarily offers clinical thermometers; blood pressure monitors; and self-test diagnostic products for women, including pregnancy tests, chlamydia tests, urinary tract infection, diverse ovulation test solutions, and pH tests. The Respiratory segment develops and manufactures products under the Spirostik and Spirostik Complete names, principally for the pulmonary and cardiopulmonary function diagnostics. The Medical Warming Systems segment provides warming systems under the UniqueTemp and Unique Resc+ brand names to maintain body temperature during operations and in rescue situations; and nomag IC, an incubator system for use in magnetic resonance imaging of premature and newborn infants under the LMT brand. The Cardio/Stroke segment offers stroke risk analysis products for the detection of atrial fibrillation used in preventing strokes. It markets its products through pharmacies, hospitals, and clinics. The company exports its products to Europe, South America, the Middle East, Asia, Africa, the United States, and internationally. Geratherm Medical AG is headquartered in Geschwenda, Germany.",
    "website": "http://www.geratherm.com",
    "zipcode": "99331"
  },
  "H9O1.F": {
    "city": "Erlangen",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "HumanOptics AG",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "HUMANOPTICS AG  O.N.",
    "state": null,
    "summary": "HumanOptics AG develops, manufactures, and sells intraocular implantable solutions. The company offers artificial intraocular lenses. It also provides CUSTOMFLEX ARTIFICIALIRIS, an iris prosthesis, which is used for the medical and aesthetic reconstruction of eyes with complete or partial aniridia; and implants and accessories. HumanOptics AG serves surgeons and patients. The company is headquartered in Erlangen, Germany. HumanOptics AG is a former subsidiary of Medipart AG.",
    "website": "http://www.humanoptics.com",
    "zipcode": "91054"
  },
  "MF6.DE": {
    "city": "Berlin",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "GER",
    "industry": "Medical Devices",
    "long_name": "MagForce AG",
    "market": "de_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "MAGFORCE AG",
    "state": null,
    "summary": "MagForce AG operates in the field of nanotechnology-based cancer treatment in Germany and Poland. It offers NanoTherm therapy for the treatment of solid tumors; NanoTherm, a ferrofluid liquid containing superparamagnetic iron oxide nano-particles that could be activated in an alternative magnetic field; NanoPlan, a therapy planning simulation software; and NanoActivator, a magnetic field applicator. The company was founded in 1997 and is headquartered in Berlin, Germany.",
    "website": "http://www.magforce.com",
    "zipcode": "12489"
  },
  "MF6.F": {
    "city": "Berlin",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "MagForce AG",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "MAGFORCE AG",
    "state": null,
    "summary": "MagForce AG operates in the field of nanotechnology-based cancer treatment in Germany and Poland. It offers NanoTherm therapy for the treatment of solid tumors; NanoTherm, a ferrofluid liquid containing superparamagnetic iron oxide nano-particles that could be activated in an alternative magnetic field; NanoPlan, a therapy planning simulation software; and NanoActivator, a magnetic field applicator. The company was founded in 1997 and is headquartered in Berlin, Germany.",
    "website": "http://www.magforce.com",
    "zipcode": "12489"
  },
  "PUS.MU": {
    "city": "Feldkirchen",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "MUN",
    "industry": "Medical Devices",
    "long_name": "PULSION Medical Systems SE",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "PULSION ST O.N.",
    "state": null,
    "summary": "PULSION Medical Systems SE engages in the development and sale of monitoring systems and disposables for diagnosis and treatment of patients worldwide. The company offers its principal products in the fields of anesthesia, surgical and internal intensive care medicine, and cardiology, as well as ophthalmology and tumor therapy. PULSION Medical Systems SE was founded in 1990 and is headquartered in Feldkirchen, Germany.",
    "website": "http://www.pulsion.com",
    "zipcode": "85622"
  },
  "SBS.DE": {
    "city": "Birkenfeld",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "GER",
    "industry": "Medical Devices",
    "long_name": "Stratec SE",
    "market": "de_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "STRATEC SE  NA O.N.",
    "state": null,
    "summary": "Stratec SE designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany and internationally. It operates through three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems, including service parts and consumables for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications. The Smart Consumables segment develops and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.",
    "website": "http://www.stratec.com",
    "zipcode": "75217"
  },
  "SBS.F": {
    "city": "Birkenfeld",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Stratec SE",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "STRATEC SE  NA O.N.",
    "state": null,
    "summary": "Stratec SE designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany and internationally. It operates through three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems, including service parts and consumables for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications. The Smart Consumables segment develops and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.",
    "website": "http://www.stratec.com",
    "zipcode": "75217"
  },
  "STSEY": {
    "city": "Birkenfeld",
    "country": "Germany",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Stratec SE",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "STRATEC SE UNSPN ADS EACH REP 0",
    "state": null,
    "summary": "Stratec SE designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany and internationally. It operates through three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems, including service parts and consumables for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications. The Smart Consumables segment develops and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.",
    "website": "http://www.stratec.com",
    "zipcode": "75217"
  }
}
